Search Results 1801-1810 of 16233 for Epilepsy (Partial Onset)

  1. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

    About this study. This study will determine the effect of QPI-1007 on visual function in subjects with recent-onset NAION and assess the safety and ...

  2. Endoscopic Necrosectomy vs. Step-up Endoscopic Interventions Pragmatic Trial - Mayo Clinic

    However, a persistent collection with pain, gastric outlet, intestinal or biliary obstruction, new-onset ... partial or complete wall). Necrotic collection ...

  3. Aging - Mayo Clinic News Network

    2018 · 2017 · 2016 · (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy. Marty Velasco Hames. April 2, 2025. For Anthony Maita, 'Buddy ...

  4. Neurosciences - 2022 Archives - Mayo Clinic News Network

    Mayo Clinic Minute: Demystifying epilepsy. Jason Howland. November 8, 2022. Ask the Mayo Mom: Navigating a new epilepsy diagnosis. Jennifer O'Hara. November 4 ...

  5. A Multi-centered, Double-blind, Randomized, Placebo-controlled Study of TEV-56286 for the Treatment of Multiple System Atrophy - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the study. Is medically and psychiatrically stable, as ...

  6. Publications - Eric J. Sorenson, M.D. - Mayo Clinic

    Kassardjian CD, Engel AG, Sorenson EJ. Electromyographic findings in 37 patients with adult-onset acid maltase deficiency. Muscle Nerve. 2015 May; 51: (5)759-61 ...

  7. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

    International normalized ratio (INR) and activated partial thromboplastin time (aPTT) below the upper limit of normal (ULN). It is expected that patients ...

  8. Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator - Mayo Clinic

    ... duration on the qualifying ECG >90 msec); Passing S-ICD Screening ECG performed per applicable user's manual on or after the consent date that identifies one ...

  9. A Study to Assess the Effectiveness and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of REGN3500 monotherapy compared with placebo treatment in adult patients with moderate-to- ...

  10. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... Patients under guardianship or partial ... epileptic therapy are allowed.